6U58 image
Entry Detail
PDB ID:
6U58
Keywords:
Title:
Toho1 Beta Lactamase Glu166Gln Mutant
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2019-08-27
Release Date:
2020-02-19
Method Details:
R-Value Free:
['0.18
R-Value Work:
['0.15
R-Value Observed:
['?', '?'].00
Space Group:
P 32 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Beta-lactamase
Mutations:E166Q
Chain IDs:A
Chain Length:261
Number of Molecules:1
Biological Source:Escherichia coli
Ligand Molecules
Primary Citation
Probing the Role of the Conserved Residue Glu166 in a Class A Beta-Lactamase Using Neutron and X-ray Protein Crystallography
Acta Crystallogr.,Sect.D 76 118 123 (2020)
PMID: 32038042 DOI: 10.1107/S2059798319016334

Abstact

The amino-acid sequence of the Toho-1 β-lactamase contains several conserved residues in the active site, including Ser70, Lys73, Ser130 and Glu166, some of which coordinate a catalytic water molecule. This catalytic water molecule is essential in the acylation and deacylation parts of the reaction mechanism through which Toho-1 inactivates specific antibiotics and provides resistance to its expressing bacterial strains. To investigate the function of Glu166 in the acylation part of the catalytic mechanism, neutron and X-ray crystallographic studies were performed on a Glu166Gln mutant. The structure of this class A β-lactamase mutant provides several insights into its previously reported reduced drug-binding kinetic rates. A joint refinement of both X-ray and neutron diffraction data was used to study the effects of the Glu166Gln mutation on the active site of Toho-1. This structure reveals that while the Glu166Gln mutation has a somewhat limited impact on the positions of the conserved amino acids within the active site, it displaces the catalytic water molecule from the active site. These subtle changes offer a structural explanation for the previously observed decreases in the binding of non-β-lactam inhibitors such as the recently developed diazobicyclooctane inhibitor avibactam.

Legend

Protein

Chemical

Disease

Primary Citation of related structures